Indrayani Biotech Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 459.95 million compared to INR 152.51 million a year ago. Revenue was INR 460.74 million compared to INR 154.04 million a year ago. Net income was INR 34.42 million compared to INR 11.45 million a year ago. Basic earnings per share from continuing operations was INR 0.72. Diluted earnings per share from continuing operations was INR 0.72.
For the nine months, sales was INR 1,136.8 million compared to INR 443.25 million a year ago. Revenue was INR 1,161.17 million compared to INR 445.41 million a year ago. Net income was INR 104.87 million compared to INR 28.31 million a year ago. Basic earnings per share from continuing operations was INR 2.24. Diluted earnings per share from continuing operations was INR 2.24.